University of Rochester Medical Center
Pathology residency · Rochester, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Rochester Medicine's research in pathology, which the program shares with other departments and affiliated hospitals.
About University of Rochester Medicineinstitution-wide pathology research
Pathology publications from University of Rochester Medicine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
69
works per year
19th of 65 pathology residency programs
+2.2%
2-year growth
39th of 65 pathology residency programs
27.7%
in top 10% of field (works before 2025)
3rd of 56 pathology residency programs
47.3%
cited above world average
13th of 56 pathology residency programs
Works per year · * 2026 so far
Pathology and Forensic Medicine · 358
Pathology research topics at University of Rochester Medicine
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Rochester Medicine since 2024
All pathology papers there on OpenAlex
- Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong‐Gyun Lee et al. · Nature · 2024 · PubMed · cited 135
- Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse B. Ercan et al. · The Lancet Oncology · 2024 · PubMed · cited 79
- Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell LymphomaFranck Morschhauser et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 56
- KMT2A regulates the autophagy-GATA4 axis through METTL3-mediated m6A modification of ATG4a to promote NPCs senescence and IVDD progressionOuqiang Wu et al. · Bone Research · 2024 · PubMed · cited 42
- You can't handle the truth! Comparing serum phosphatidylethanol to self-reported alcohol intake in chronic liver disease patientsKyle Scholten et al. · Digestive and Liver Disease · 2024 · PubMed · cited 42
- Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826Sarah C. Rutherford et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 36
- Defining primary refractory large B-cell lymphomaAllison Marie Bock et al. · Blood Advances · 2024 · PubMed · cited 35
- The role of miR-155-5p in inflammation and mechanical loading during intervertebral disc degenerationPetra Cazzanelli et al. · Cell Communication and Signaling · 2024 · PubMed · cited 33
- Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized TrialTimothy S. Fenske et al. · Blood · 2024 · cited 28
- The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R. Cerhan et al. · American Journal of Hematology · 2024 · PubMed · cited 27